Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Adhesion Barrier Market by Type (Synthetic Adhesion Barrier, Natural Adhesion Barrier) , by Application (General/Abdominal Surgeries, Gynecological Surgeries, Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Other Applications) by End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033

A09554

Pages: 280

Charts: 61

Tables: 138

Adhesion Barrier Market Research, 2033

The global adhesion barrier market size was valued at $0.7 billion in 2023, and is projected to reach $1.5 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033. The major factors driving the growth of the adhesion barrier market are rise in number of the surguries performed globally, increase in awareness among healthcare professionals about the complications associated with adhesions, and rise in research and development to develope innovative adhesion barrier products. 

 

Market Introduction and Definition

Adhesion barrier is a medical device used during surgeries to prevent the formation of adhesions, which are abnormal connections between tissues or organs that can occur after surgery. Adhesion barriers are composed of biocompatible materials such as films, gels, or fabrics that are placed between the tissues being operated on to act as a physical barrier. The primary purpose of adhesion barriers is to reduce the risk of adhesion-related complications, such as bowel obstructions, infertility, and chronic pain, which can arise when tissues become stuck together during the healing process. Adhesion barriers work by creating a temporary barrier between tissues, preventing them from sticking together as they heal. Adhesion barriers are particularly useful in surgeries involving the abdomen, pelvis, and other areas where tissues are prone to adhere. 

Key Takeaways 

  • The adhesion barrier market share study covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period 2024-2032.
  • More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major energy storage system industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
  • The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions to achieve their most ambitious growth objectives

 Key Market Segments

  • By Type
    • Synthetic Adhesion Barrier
    • Natural Adhesion Barrier
  • By Application
    • General/Abdominal Surgeries
    • Gynecological Surgeries
    • Cardiovascular Surgeries
    • Orthopedic Surgeries
    • Neurological Surgeries
    • Other Applications
  • By End User
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • Australia
      • India
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest of LAMEA

 
Key Market Players

  • Toray Industries Inc.
  • Baxter International Inc.
  • fziomed, inc.
  • Betatech Medical
  • Integra LifeSciences Holdings Corporation
  • Atrium Medical Corporation
  • Anika Therapeutics Inc.
  • leader biomedical
  • Johnson & Johnson
  • CGBio Inc

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: ADHESION BARRIER MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Synthetic Adhesion Barrier

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Natural Adhesion Barrier

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: ADHESION BARRIER MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. General/Abdominal Surgeries

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Gynecological Surgeries

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Cardiovascular Surgeries

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Orthopedic Surgeries

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Neurological Surgeries

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Other Applications

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

  • CHAPTER 6: ADHESION BARRIER MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Specialty Clinics

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Ambulatory Surgical Centers

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: ADHESION BARRIER MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Type

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Adhesion Barrier Market

        • 7.2.6.1. Market Size and Forecast, By Type
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By End User

      • 7.2.7. Canada Adhesion Barrier Market

        • 7.2.7.1. Market Size and Forecast, By Type
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By End User

      • 7.2.8. Mexico Adhesion Barrier Market

        • 7.2.8.1. Market Size and Forecast, By Type
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By End User

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Type

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Adhesion Barrier Market

        • 7.3.6.1. Market Size and Forecast, By Type
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By End User

      • 7.3.7. Germany Adhesion Barrier Market

        • 7.3.7.1. Market Size and Forecast, By Type
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By End User

      • 7.3.8. Italy Adhesion Barrier Market

        • 7.3.8.1. Market Size and Forecast, By Type
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By End User

      • 7.3.9. Spain Adhesion Barrier Market

        • 7.3.9.1. Market Size and Forecast, By Type
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By End User

      • 7.3.10. UK Adhesion Barrier Market

        • 7.3.10.1. Market Size and Forecast, By Type
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By End User

      • 7.3.11. Russia Adhesion Barrier Market

        • 7.3.11.1. Market Size and Forecast, By Type
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By End User

      • 7.3.12. Rest Of Europe Adhesion Barrier Market

        • 7.3.12.1. Market Size and Forecast, By Type
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By End User

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Type

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Adhesion Barrier Market

        • 7.4.6.1. Market Size and Forecast, By Type
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By End User

      • 7.4.7. Japan Adhesion Barrier Market

        • 7.4.7.1. Market Size and Forecast, By Type
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By End User

      • 7.4.8. India Adhesion Barrier Market

        • 7.4.8.1. Market Size and Forecast, By Type
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By End User

      • 7.4.9. South Korea Adhesion Barrier Market

        • 7.4.9.1. Market Size and Forecast, By Type
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By End User

      • 7.4.10. Australia Adhesion Barrier Market

        • 7.4.10.1. Market Size and Forecast, By Type
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By End User

      • 7.4.11. Thailand Adhesion Barrier Market

        • 7.4.11.1. Market Size and Forecast, By Type
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By End User

      • 7.4.12. Malaysia Adhesion Barrier Market

        • 7.4.12.1. Market Size and Forecast, By Type
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By End User

      • 7.4.13. Indonesia Adhesion Barrier Market

        • 7.4.13.1. Market Size and Forecast, By Type
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By End User

      • 7.4.14. Rest of Asia Pacific Adhesion Barrier Market

        • 7.4.14.1. Market Size and Forecast, By Type
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By End User

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Type

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Adhesion Barrier Market

        • 7.5.6.1. Market Size and Forecast, By Type
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By End User

      • 7.5.7. South Africa Adhesion Barrier Market

        • 7.5.7.1. Market Size and Forecast, By Type
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By End User

      • 7.5.8. Saudi Arabia Adhesion Barrier Market

        • 7.5.8.1. Market Size and Forecast, By Type
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By End User

      • 7.5.9. UAE Adhesion Barrier Market

        • 7.5.9.1. Market Size and Forecast, By Type
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By End User

      • 7.5.10. Argentina Adhesion Barrier Market

        • 7.5.10.1. Market Size and Forecast, By Type
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By End User

      • 7.5.11. Rest of LAMEA Adhesion Barrier Market

        • 7.5.11.1. Market Size and Forecast, By Type
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By End User

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Anika Therapeutics Inc.

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Baxter International Inc.

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Leader Biomedical

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Betatech Medical

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Fziomed, Inc.

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Integra LifeSciences Holdings Corporation

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Johnson And Johnson

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. CGBio Inc

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Atrium Medical Corporation

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Toray Industries Inc.

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL ADHESION BARRIER MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL ADHESION BARRIER MARKET FOR NATURAL ADHESION BARRIER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL ADHESION BARRIER MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL ADHESION BARRIER MARKET FOR GENERAL/ABDOMINAL SURGERIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL ADHESION BARRIER MARKET FOR GYNECOLOGICAL SURGERIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL ADHESION BARRIER MARKET FOR CARDIOVASCULAR SURGERIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL ADHESION BARRIER MARKET FOR ORTHOPEDIC SURGERIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL ADHESION BARRIER MARKET FOR NEUROLOGICAL SURGERIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL ADHESION BARRIER MARKET FOR OTHER APPLICATIONS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL ADHESION BARRIER MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL ADHESION BARRIER MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL ADHESION BARRIER MARKET FOR SPECIALTY CLINICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL ADHESION BARRIER MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL ADHESION BARRIER MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA ADHESION BARRIER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 20. U.S. ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 21. U.S. ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 22. U.S. ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 23. CANADA ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 24. CANADA ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 25. CANADA ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 26. MEXICO ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 27. MEXICO ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 28. MEXICO ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 29. EUROPE ADHESION BARRIER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 31. EUROPE ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 32. EUROPE ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 33. FRANCE ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 34. FRANCE ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 35. FRANCE ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 36. GERMANY ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 37. GERMANY ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 38. GERMANY ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 39. ITALY ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 40. ITALY ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 41. ITALY ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 42. SPAIN ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 43. SPAIN ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 44. SPAIN ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 45. UK ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 46. UK ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 47. UK ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 48. RUSSIA ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 49. RUSSIA ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 50. RUSSIA ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 51. REST OF EUROPE ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 52. REST OF EUROPE ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 53. REST OF EUROPE ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 54. ASIA-PACIFIC ADHESION BARRIER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 55. ASIA-PACIFIC ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 56. ASIA-PACIFIC ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 57. ASIA-PACIFIC ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 58. CHINA ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 59. CHINA ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 60. CHINA ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 61. JAPAN ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 62. JAPAN ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 63. JAPAN ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 64. INDIA ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 65. INDIA ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 66. INDIA ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 67. SOUTH KOREA ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH KOREA ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 69. SOUTH KOREA ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 70. AUSTRALIA ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 71. AUSTRALIA ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 72. AUSTRALIA ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 73. THAILAND ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 74. THAILAND ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 75. THAILAND ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 76. MALAYSIA ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 77. MALAYSIA ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 78. MALAYSIA ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 79. INDONESIA ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 80. INDONESIA ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 81. INDONESIA ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 85. LAMEA ADHESION BARRIER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 86. LAMEA ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 87. LAMEA ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 88. LAMEA ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 89. BRAZIL ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 90. BRAZIL ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 91. BRAZIL ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 92. SOUTH AFRICA ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 93. SOUTH AFRICA ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 94. SOUTH AFRICA ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 95. SAUDI ARABIA ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 96. SAUDI ARABIA ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 97. SAUDI ARABIA ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 98. UAE ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 99. UAE ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 100. UAE ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 101. ARGENTINA ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 102. ARGENTINA ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 103. ARGENTINA ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 104. REST OF LAMEA ADHESION BARRIER, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 105. REST OF LAMEA ADHESION BARRIER, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 106. REST OF LAMEA ADHESION BARRIER, BY END USER, 2025-2033 ($MILLION)
  • TABLE 107. ANIKA THERAPEUTICS INC.: KEY EXECUTIVES
  • TABLE 108. ANIKA THERAPEUTICS INC.: COMPANY SNAPSHOT
  • TABLE 109. ANIKA THERAPEUTICS INC.: OPERATING SEGMENTS
  • TABLE 110. ANIKA THERAPEUTICS INC.: PRODUCT PORTFOLIO
  • TABLE 111. ANIKA THERAPEUTICS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. BAXTER INTERNATIONAL INC.: KEY EXECUTIVES
  • TABLE 113. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
  • TABLE 114. BAXTER INTERNATIONAL INC.: OPERATING SEGMENTS
  • TABLE 115. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
  • TABLE 116. BAXTER INTERNATIONAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. LEADER BIOMEDICAL: KEY EXECUTIVES
  • TABLE 118. LEADER BIOMEDICAL: COMPANY SNAPSHOT
  • TABLE 119. LEADER BIOMEDICAL: OPERATING SEGMENTS
  • TABLE 120. LEADER BIOMEDICAL: PRODUCT PORTFOLIO
  • TABLE 121. LEADER BIOMEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. BETATECH MEDICAL: KEY EXECUTIVES
  • TABLE 123. BETATECH MEDICAL: COMPANY SNAPSHOT
  • TABLE 124. BETATECH MEDICAL: OPERATING SEGMENTS
  • TABLE 125. BETATECH MEDICAL: PRODUCT PORTFOLIO
  • TABLE 126. BETATECH MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 127. FZIOMED, INC.: KEY EXECUTIVES
  • TABLE 128. FZIOMED, INC.: COMPANY SNAPSHOT
  • TABLE 129. FZIOMED, INC.: OPERATING SEGMENTS
  • TABLE 130. FZIOMED, INC.: PRODUCT PORTFOLIO
  • TABLE 131. FZIOMED, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 132. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY EXECUTIVES
  • TABLE 133. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • TABLE 134. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: OPERATING SEGMENTS
  • TABLE 135. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 136. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 137. JOHNSON AND JOHNSON: KEY EXECUTIVES
  • TABLE 138. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
  • TABLE 139. JOHNSON AND JOHNSON: OPERATING SEGMENTS
  • TABLE 140. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
  • TABLE 141. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. CGBIO INC: KEY EXECUTIVES
  • TABLE 143. CGBIO INC: COMPANY SNAPSHOT
  • TABLE 144. CGBIO INC: OPERATING SEGMENTS
  • TABLE 145. CGBIO INC: PRODUCT PORTFOLIO
  • TABLE 146. CGBIO INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. ATRIUM MEDICAL CORPORATION: KEY EXECUTIVES
  • TABLE 148. ATRIUM MEDICAL CORPORATION: COMPANY SNAPSHOT
  • TABLE 149. ATRIUM MEDICAL CORPORATION: OPERATING SEGMENTS
  • TABLE 150. ATRIUM MEDICAL CORPORATION: PRODUCT PORTFOLIO
  • TABLE 151. ATRIUM MEDICAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. TORAY INDUSTRIES INC.: KEY EXECUTIVES
  • TABLE 153. TORAY INDUSTRIES INC.: COMPANY SNAPSHOT
  • TABLE 154. TORAY INDUSTRIES INC.: OPERATING SEGMENTS
  • TABLE 155. TORAY INDUSTRIES INC.: PRODUCT PORTFOLIO
  • TABLE 156. TORAY INDUSTRIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL ADHESION BARRIER MARKET SEGMENTATION
  • FIGURE 2. GLOBAL ADHESION BARRIER MARKET
  • FIGURE 3. SEGMENTATION ADHESION BARRIER MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN ADHESION BARRIER MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALADHESION BARRIER MARKET
  • FIGURE 11. ADHESION BARRIER MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIER, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. ADHESION BARRIER MARKET FOR NATURAL ADHESION BARRIER, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. ADHESION BARRIER MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 15. ADHESION BARRIER MARKET FOR GENERAL/ABDOMINAL SURGERIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. ADHESION BARRIER MARKET FOR GYNECOLOGICAL SURGERIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. ADHESION BARRIER MARKET FOR CARDIOVASCULAR SURGERIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. ADHESION BARRIER MARKET FOR ORTHOPEDIC SURGERIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. ADHESION BARRIER MARKET FOR NEUROLOGICAL SURGERIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. ADHESION BARRIER MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. ADHESION BARRIER MARKET SEGMENTATION, BY BY END USER
  • FIGURE 22. ADHESION BARRIER MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. ADHESION BARRIER MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. ADHESION BARRIER MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 26. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 27. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 28. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 29. COMPETITIVE DASHBOARD
  • FIGURE 30. COMPETITIVE HEATMAP: ADHESION BARRIER MARKET
  • FIGURE 31. TOP PLAYER POSITIONING, 2024
  • FIGURE 32. ANIKA THERAPEUTICS INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. ANIKA THERAPEUTICS INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. ANIKA THERAPEUTICS INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. BAXTER INTERNATIONAL INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. BAXTER INTERNATIONAL INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. BAXTER INTERNATIONAL INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. LEADER BIOMEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. LEADER BIOMEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. LEADER BIOMEDICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. BETATECH MEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. BETATECH MEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. BETATECH MEDICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. FZIOMED, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. FZIOMED, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. FZIOMED, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. JOHNSON AND JOHNSON: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. CGBIO INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. CGBIO INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. CGBIO INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. ATRIUM MEDICAL CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. ATRIUM MEDICAL CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. ATRIUM MEDICAL CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 59. TORAY INDUSTRIES INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 60. TORAY INDUSTRIES INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 61. TORAY INDUSTRIES INC.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Adhesion Barrier Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved